Loading...
3. How comprehensive can we be in the economic assessment of vaccines?
In two previous papers we argued on current vaccines economic assessment not fully comprehensive when using the incremental cost-utility analysis normally applied for treatments. Many differences exist between vaccines and drug treatments making vaccines economic evaluation more cumbersome. Four cha...
Saved in:
| Published in: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Routledge
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956290/ https://ncbi.nlm.nih.gov/pubmed/29785253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2017.1336044 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|